Congenital hypofibrinogenemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
6
|
10
|
0.740 |
strong |
1.000 |
9 |
3
|
2000 |
2018 |
Fibrinogen Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
56
|
4
|
0.700 |
strong |
1.000 |
10 |
1
|
2005 |
2018 |
Dysfibrinogenemia, Congenital
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
6
|
8
|
0.610 |
strong |
1.000 |
7 |
5
|
1986 |
2018 |
Afibrinogenemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
9
|
|
0.530 |
None |
1.000 |
5 |
|
2000 |
2004 |
Hypodysfibrinogenemia
|
disease |
|
Disease or Syndrome
|
8
|
1
|
0.440 |
strong |
1.000 |
4 |
1
|
2015 |
2019 |
Malignant neoplasm of stomach
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3806
|
615
|
0.310 |
None |
1.000 |
2 |
|
2009 |
2018 |
Keloid
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Acquired Abnormality
|
165
|
15
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Stomach Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
820
|
55
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Hereditary Diffuse Gastric Cancer
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
312
|
119
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Pancreatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
502
|
80
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.200 |
None |
1.000 |
1 |
|
2006 |
2006 |
Pulmonary Embolism
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Pathologic Function
|
93
|
16
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Inflammation
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
467
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Injury of liver
|
disease |
Digestive System Diseases; Wounds and Injuries
|
Injury or Poisoning
|
36
|
|
0.200 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hypofibrinogenemia
|
disease |
|
Disease or Syndrome
|
60
|
14
|
0.190 |
None |
1.000 |
10 |
4
|
2005 |
2019 |
Venous Thromboembolism
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
378
|
408
|
0.160 |
None |
1.000 |
8 |
3
|
2011 |
2019 |
Venous Thrombosis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
117
|
218
|
0.110 |
None |
1.000 |
2 |
4
|
2007 |
2012 |
Fibrinogen assay
|
phenotype |
|
Laboratory Procedure
|
55
|
143
|
0.100 |
None |
1.000 |
2 |
2
|
2011 |
2016 |
fibrinogen activity
|
phenotype |
|
Molecular Function
|
26
|
63
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Glycine measurement
|
phenotype |
|
Laboratory Procedure
|
32
|
68
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Fibrinogen, CTCAE
|
phenotype |
|
Finding
|
26
|
63
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Bleeding tendency
|
phenotype |
Hemic and Lymphatic Diseases
|
Pathologic Function
|
71
|
14
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Intermenstrual heavy bleeding
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications
|
Sign or Symptom
|
10
|
1
|
0.100 |
None |
|
0 |
|
|
|
Joint swelling
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
33
|
|
0.100 |
None |
|
0 |
|
|
|